Trade Madrigal Pharmaceuticals, Inc. (Extended hours) - MDGL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.96 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023485% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001262% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 330.51 |
| Open | 327.2 |
| 1-Year Change | 22.64% |
| Day's Range | 320.32 - 333.89 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | 330.51 | 10.56 | 3.30% | 319.95 | 332.27 | 307.17 |
| Mar 28, 2025 | 322.71 | -8.27 | -2.50% | 330.98 | 335.21 | 322.71 |
| Mar 27, 2025 | 334.92 | 4.96 | 1.50% | 329.96 | 337.49 | 329.96 |
| Mar 26, 2025 | 329.95 | -9.75 | -2.87% | 339.70 | 342.45 | 329.95 |
| Mar 25, 2025 | 341.33 | -3.10 | -0.90% | 344.43 | 350.65 | 334.95 |
| Mar 24, 2025 | 338.45 | -7.49 | -2.17% | 345.94 | 347.25 | 337.95 |
| Mar 21, 2025 | 343.56 | 8.45 | 2.52% | 335.11 | 343.75 | 330.95 |
| Mar 20, 2025 | 335.05 | -6.13 | -1.80% | 341.18 | 341.18 | 329.96 |
| Mar 19, 2025 | 335.15 | -5.29 | -1.55% | 340.44 | 340.88 | 330.78 |
| Mar 18, 2025 | 336.35 | -6.53 | -1.90% | 342.88 | 343.20 | 330.03 |
| Mar 17, 2025 | 340.35 | -7.40 | -2.13% | 347.75 | 348.45 | 336.12 |
| Mar 14, 2025 | 339.95 | 24.00 | 7.60% | 315.95 | 347.96 | 315.95 |
| Mar 13, 2025 | 323.84 | -4.40 | -1.34% | 328.24 | 331.99 | 319.95 |
| Mar 12, 2025 | 323.95 | -5.98 | -1.81% | 329.93 | 340.20 | 318.85 |
| Mar 11, 2025 | 335.85 | 8.76 | 2.68% | 327.09 | 335.85 | 314.95 |
| Mar 10, 2025 | 321.95 | -1.95 | -0.60% | 323.90 | 332.68 | 321.95 |
| Mar 7, 2025 | 323.91 | -3.04 | -0.93% | 326.95 | 339.50 | 322.37 |
| Mar 6, 2025 | 326.95 | -9.97 | -2.96% | 336.92 | 348.88 | 326.95 |
| Mar 5, 2025 | 343.58 | 22.23 | 6.92% | 321.35 | 348.35 | 319.59 |
| Mar 4, 2025 | 328.16 | 13.01 | 4.13% | 315.15 | 328.16 | 299.08 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Madrigal Pharmaceuticals, Inc. Company profile
About Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The Company’s lead product candidate, MGL-3196 (resmetirom), is a liver-directed, selective thyroid hormone receptor-ß (THR-ß) agonist for the treatment of non-alcoholic steatohepatitis (NASH)and heterozygous familial hypercholesterolemia (HeFH). Its product pipeline also includes MGL-3745, which is used in the treatment of NASH and HeFH.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Madrigal Pharmaceuticals Inc revenues was not reported. Net loss increased 20% to $241.8M. Higher net loss reflects R & D increase of 11% to $194.5M (expense), G & A increase from $10M to $21.1M (expense), Stock-based Compensation in SGA increase of 36% to $16.2M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$13.09 to -$14.63.
Equity composition
Common Stock $.0001 Par, 10/10, 100M auth., 42,166,779 issd. Insiders control approx. 37.8%. IPO: 2/06/07, 5M shares @ $10 per share by Bear, Stearns & Co. Inc.
| Industry: | Bio Therapeutic Drugs |
200 Barr Harbor Dr Ste 400
WEST CONSHOHOCKEN
PENNSYLVANIA 19428-2978
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com